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Chemistry and Pharmacology of Anticancer Drugs by David E
Thurston has tackled a mountain of information that exists
regarding the current state of cancer chemotherapy. The sheer
volume of information published on both cancer and chemother-
apeutics is frequently discouraging to novice cancer researchers
and often turns them away from investigations on the action or
activity of new drugs alone or in the combination. This book is
written in a style that is easily understood and fairly comprehen-
sive without delving into elaborate dosing tables and various
regimens for delivery. As written, the book does an excellent job
for its intended target audience of advanced undergraduates and
health-care professionals in training or those with only peripheral
exposure to cancer therapy.
The book begins with a very brief introduction to cancer that
includes: basic terminology of cancer and metastasis, staging and
grading, treatment options, evaluation of chemotherapeutics,
limiting toxicity and mechanisms of chemotherapy that are
sufficient but will not impress the professional cancer researcher
or clinician. However, the information is presented in a manner
that will appeal to professionals or students who desire a rapid
overview in this area. After this introduction, the book discusses
chemotherapeutic compounds by class, in a manner reminiscent of
more clinically rich clinical oncology texts: anti-metabolites, DNA
interactive, anti-tubulin, molecular pathway targets and hormonal
pathway targets. The author discusses each compound of every class;
the class of compound is followed by detailed descriptions of the
structure and mechanism of each drug in its class. Toxicities, side
effects and current proscribed uses are included, but only as used in
the United Kingdom. For those readers who are interested in a
source that compiles chemotherapeutics by class and mechanism in
a single table, keep waiting. This is one big deficiency of the text.
Typically, these tables were provided with administration routes and
scheduling information that made them too cumbersome for all but
the clinical user. The author has missed a major opportunity to
simplify a summary presentation.
After this, the book takes a turn towards an examination of more
novel and experimental therapies, something usually not found in
books that are targeted at the advanced undergraduate to early
graduate student level. Essentially, the book handles topics on
tumour targeting strategies using antibodies and antivascular
approaches as well as bioreductive agents. This trend is continued
in the chapter on biological agents, which includes information on
biological response modifiers and modulation of the immune
system including vaccines. The book then delves into treatments
on the horizon that are based upon fairly recent basic and
translational research. The author provides a very nice overview of
the number of strategies and the specificity for targeting cancer
resistance, growth factor signalling pathways and the integration of
genomics and proteomic responses for tailoring or determining if
treatments are successful. This is followed-up in a later chapter on
personalised medicine, which also includes a section on predicting
adverse effects to chemotherapy. This section concludes with a
brief overview of chemoprevention strategies and the most
favoured chemoprevention agents that are used currently; the
section also includes a discussion, or at least a speculation, of their
mechanism of action. The book concludes with a section on
adjunct therapies to ease major side effects and improve patient
tolerance of therapy.
It is a minor source of irritation that once drugs have been
discussed at length they are no longer page referenced in the text
and are referred to only by the trade name and not by the
compound name, which is how they are listed most commonly in
the index. This has the reader referring to the table of contents and
the individual drug sections to try to refresh their memory of
drugs as they come back into discussion in the text through a
different context. Better cross-listing of compounds and a more
complete index is needed but is not a major distraction.
In short, the back jacket description is quite accurate and the
book does not disappoint given the target audience. Finding drugs
through the table of contents or through the index is sufficient.
Overall, the book is easy to read and manages to not be redundant.
This is all quite an accomplishment considering the topic.
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